Zobrazeno 1 - 10
of 150
pro vyhledávání: '"M S Hirsch"'
Publikováno v:
WHO/IARC Classification of Tumours; 2022, Vol. 8, p87-89, 3p
Publikováno v:
Journal of Virology. 70:7725-7733
Disseminated cytomegalovirus (CMV) infection is a frequent occurrence in human immunodeficiency virus-infected humans and in simian immunodeficiency virus (SIV)-infected rhesus macaques. Rhesus macaques are a suitable animal model with which to study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3f62313b1b89f8c9159159331f06ef
https://doi.org/10.1128/jvi.70.11.7725-7733.1996
https://doi.org/10.1128/jvi.70.11.7725-7733.1996
Autor:
W D Hardy, Mohan Beltangady, Margaret A. Fischl, S. H. Liou, Raphael Dolin, Michael J. Brown, Carla Pettinelli, David A. Amato, Anne Cross, M. S. Hirsch
Publikováno v:
Archives of Internal Medicine. 155:961-974
BACKGROUND We conducted a trial to compare treatment with zidovudine or didanosine in patients with advanced human immunodeficiency virus type 1 (HIV-1) infection who had received little or no previous therapy with zidovudine. METHODS Six hundred sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eadea62e29acbd6284ee232ac86240f8
https://doi.org/10.1001/archinte.155.9.961
https://doi.org/10.1001/archinte.155.9.961
Autor:
Richard T. D'Aquila, Debra P. Merrill, M. S. Hirsch, T. Mazzulli, Stefano Rusconi, Majaz Moonis, Ting-Chao Chou
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:656-661
We compared the in vitro efficacies of two-, three-, and four-drug combinations given continuously or in alternating regimens against a clinical isolate of human immunodeficiency virus type 1. In H9 cells and peripheral blood mononuclear cells, at th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3428c00e6ee70267a88fa5284e67ee4
https://doi.org/10.1128/aac.38.4.656
https://doi.org/10.1128/aac.38.4.656
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:1559-1562
The combination of zidovudine (AZT) and 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 (HIV-1) replication in vitro with AZT-sensitive and AZT-resistant clinical isolates and HIV-1IIIB. Synergy was determined by th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6882de27ec11a2dd5e950d3ad4741c6a
https://doi.org/10.1128/aac.36.7.1559
https://doi.org/10.1128/aac.36.7.1559
Publikováno v:
WHO/IARC Classification of Tumours; 2022, Vol. 8, p92-93, 2p
Autor:
M S Osburne, P V Pallai, Majaz Moonis, S K Singh, K J Willis, Edith A. Neidhardt, J C Jenson, A T Profy, M. S. Hirsch, Stefano Rusconi, Debra P. Merrill
Publikováno v:
Scopus-Elsevier
PIC 024-4 and PRO 2000 are naphthalene sulfonate polymers that bind to CD4 with nanomolar affinity and block binding of gp120. Both have activity against human immunodeficiency virus type 1 in H9 cells, peripheral blood mononuclear cells, and primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64e759cf218b4c1d5936550974d2e1e
https://doi.org/10.1128/aac.40.1.234
https://doi.org/10.1128/aac.40.1.234
Autor:
Adriana Weinberg, Michelle A. Kendall, Alejo Erice, M. S. Hirsch, Bruce Polsky, Courtney N. Tierney, Angela M. Caliendo
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 37(4)
We undertook a prospective study to analyze cytomegalovirus (CMV) end-organ disease (EOD) in subjects with advanced human immunodeficiency virus (HIV) infection. Of 403 individuals without prior CMV EOD who were followed up for a median of 151 weeks,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d0c63a03875106c03dba8c95aa871f
https://pubmed.ncbi.nlm.nih.gov/12905142
https://pubmed.ncbi.nlm.nih.gov/12905142
Publikováno v:
Antiviral therapy. 4(1)
Can aggressive anti-human immunodeficiency virus (HIV) induction regimens be simplified after sufficient virus suppression is achieved? In vitro studies were conducted to evaluate the hypothesis that aggressive induction regimens could be followed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0faca99ab8158680354193ba9f55073e
https://pubmed.ncbi.nlm.nih.gov/10682126
https://pubmed.ncbi.nlm.nih.gov/10682126
Autor:
X J, Zhou, L B, Sheiner, R T, D'Aquila, M D, Hughes, M S, Hirsch, M A, Fischl, V A, Johnson, M, Myers, J P, Sommadossi
Publikováno v:
Antimicrobial agents and chemotherapy. 43(1)
The population pharmacokinetics of nevirapine (NVP), zidovudine (ZDV), and didanosine (ddI) were evaluated in a total of 175 patients infected with human immunodeficiency virus randomized to receive either a double combination of ZDV plus ddI or a tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85756c959d98e29bab60a375b8b44186
https://pubmed.ncbi.nlm.nih.gov/9869576
https://pubmed.ncbi.nlm.nih.gov/9869576